ANTI-JO-1 ANTIBODY-ASSOCIATED CLINICALLY AMYOPATHIC DERMATOMYOSITIS WITH RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE

被引：0
|
作者：
Naeem, Ifrah
Janga, Chaitra
Khan, Aamna
Muhammad, Malik
Khan, Uzair
Patel, Rajesh R.
Sadiq, Usama
Okoyeze, Kimberley
Kramer, Mackenzie
Patel, Tirth
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.1034
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1295A / 1296A
页数：2
相关论文
共 50 条
  • [31] SUCCESSFUL MANAGEMENT OF CLINICALLY AMYOPATHIC HYPOMYOPATHIC DERMATOMYOSITIS WITH RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE (ILD): A CASE REPORT
    Chandrasekaran, Sai Harini
    Pugazhendi, Inban
    Rameshkumar, Sai Sakthi
    Chandrasekaran, Vishnu Priya
    Srinivasan, Amitesh Krishna
    CHEST, 2024, 166 (04) : 3461A - 3462A
  • [32] Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis
    Tanaka, Maki
    Arita, Machiko
    Tachibana, Hiromasa
    Ishida, Tadashi
    Nakazawa, Takashi
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [33] Rapidly progressive interstitial lung disease in a patient with anti-MDA5-positive amyopathic dermatomyositis
    Nandy, A.
    Gaini, S.
    Sore, P.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (04) : 334 - 335
  • [34] A SUBLUXING ARTHROPATHY ASSOCIATED WITH THE ANTI-JO-1 ANTIBODY IN POLYMYOSITIS DERMATOMYOSITIS
    ODDIS, CV
    MEDSGER, TA
    COOPERSTEIN, LA
    ARTHRITIS AND RHEUMATISM, 1990, 33 (11): : 1640 - 1645
  • [35] Therapeutic plasma exchange for clinically amyopathic dermatomyositis (CADM) associated with rapidly progressive interstitial pneumonia
    Yamagata, Akira
    Arita, Machiko
    Tanaka, Ayaka
    Tokioka, Fumiaki
    Yoshida, Tomohiro
    Nishimura, Keisuke
    Ishida, Tadashi
    JOURNAL OF CLINICAL APHERESIS, 2020, 35 (05) : 435 - 443
  • [36] Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis
    Kang, Eun Ha
    Nakashima, Ran
    Mimori, Tsuneyo
    Kim, Jinhyun
    Lee, Yun Jong
    Lee, Eun Bong
    Song, Yeong Wook
    BMC MUSCULOSKELETAL DISORDERS, 2010, 11
  • [37] Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis
    Eun Ha Kang
    Ran Nakashima
    Tsuneyo Mimori
    Jinhyun Kim
    Yun Jong Lee
    Eun Bong Lee
    Yeong Wook Song
    BMC Musculoskeletal Disorders, 11
  • [38] Successful treatment with tofacitinib for relapse of rapidly progressive interstitial lung disease in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
    Hama, Satoshi
    Akiyama, Mitsuhiro
    Higashida-Konishi, Misako
    Oshige, Tatsuhiro
    Takei, Hiroshi
    Izumi, Keisuke
    Oshima, Hisaji
    Okano, Yutaka
    MODERN RHEUMATOLOGY CASE REPORTS, 2023, 7 (01) : 92 - 95
  • [39] A RARE CASE OF RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN A PATIENT WITH CLINICALLY AMYOPATHIC DERMATOMYOSITIS WITH ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED GENE 5 ANTIBODIES
    Mahajan, Pranav
    Upadhyay, Riddhi
    Aedma, Surya
    Khan, Muhammad Talha
    Thameem, Danish
    CHEST, 2020, 158 (04) : 1165A - 1166A
  • [40] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
    Ho So
    Victor Tak Lung Wong
    Virginia Weng Nga Lao
    Hin Ting Pang
    Ronald Man Lung Yip
    Clinical Rheumatology, 2018, 37 : 1983 - 1989
12345